Parallel Advisors »

Aeglea Biotherapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $22 1 22.00

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Guggenheim Etf Trust S&p 500 Equal Weight Etf (RSP)
Ishares Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)

View all positions for Parallel Advisors

Top funds holding Aeglea Biotherapeutics

Perceptive Advisors
VR Adviser
Commodore Capital
venBio Select Advisor
Cormorant Asset Management
EcoR1 Capital
Franklin Resources
BVF
Wellington Management Company
Citadel Advisors
Braidwell
Global Endowment Management
First Turn Management
Fairmount Funds Management
Boxer Capital

View all funds holding Aeglea Biotherapeutics